Symbia Pro.Specta X7
Payments companies reported to CMS as associated with Symbia Pro.Specta X7. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Symbia Pro.Specta X7, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Symbia Pro.Specta X7
These are the largest totals companies reported as associated with Symbia Pro.Specta X7. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Munir Ghesani | Princeton, NJ | Nuclear Medicine | $164.95 |
| Michael Morris | Glen Burnie, MD | Diagnostic Radiology | $164.95 |
| Babak Saboury Sichani | Baltimore, MD | Diagnostic Radiology | $164.95 |
| Eliot Siegel | Baltimore, MD | Diagnostic Radiology | $164.95 |
| Srinivasan Vijayakumar | Jackson, MS | Radiation Oncology | $115.11 |
| Vani Vijayakumar | New Orleans, LA | Nuclear Medicine | $115.11 |
| Elcin Zan | New York, NY | Nuclear Imaging & Therapy | $21.02 |
| Nicholas Austin | Cleveland, OH | Diagnostic Radiology | $21.02 |
Prescribed Symbia Pro.Specta X7?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.